Selected Publications
Connor MP, Loren AW, Hexner EO, Martin ME, Gill SI, Luger SM, Mangan JK, Perl AE, McCurdy SR, Pratz KW, Timlin C, Freyer CW, Carulli A, Catania C, Smith J, Hollander L, Zebrowski AM, Stadtmauer EA, Porter DL, Frey NV.: Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies Transplant Cell Ther : 2023.
Hexner EO.: The splendor and the tyranny of JAK inhibition. Haematologica : 2023.
Zev Binder, Stephen J Bagley, Lamia Lamrani, Eliana Marinari, Arati Desai, MacLean P Nasrallah, Eileen Maloney, Steven Brem, Robert A Lustig, Goldie Kurtz, Michelle Alonso-Basanta, Pierre-Emmanuel Bonte, Christel Goudot, Wilfrid Richer, Eliane Piaggio, Shawn Kothari, Lea Guyonnet, Coralie Guerin, Joshua Waterfall, Suyash Mohan, Wei-Ting Hwang, Oliver Tang, Meghan Logun, Meghna Bhattacharyya, Kelly Markowitz, Devora Delman, Amy Marshall, E John Wherry, Sebastian Amigorena, Gregory Beatty, Jennifer Brogdon, Elizabeth Hexner, Denis Migliorini, Cecile Alanio, Donald M O'Rourke: CTIM-24. REPEATED PERIPHERAL INFUSIONS OF ANTI-EGFRVIII CAR T CELLS IN COMBINATION WITH PEMBROLIZUMAB REMODELS THE TUMOR MICROENVIRONMENT IN DE NOVO GLIOBLASTOMA Neuro-Oncology : 2023.
EO Hexner: Hematopoietic Stem Cell Transplant (HSCT) Fact Sheet for Healthcare Professionals The Leukemia & Lymphoma Society : 2023.
Wang Y, He S, Calendo G, Bui T, Tian Y, Lee CY, Zhou Y, Zhao X, Abraham C, Mo W, Chen M, Sanders-Braggs R, Madzo J, Issa JJ, Hexner EO, Wiest DL, Reshef R, Xue HH, Zhang Y.: Tissue-infiltrating Alloreactive T Cells Require Id3 to Deflect PD-1-mediated Immune Suppression during GVHD Blood : 2023.
Matthews AH, Perl AE, Luger SM, Gill SI, Lai C, Porter DL, Skuli S, Bruno XJ, Carroll MP, Freyer CW, Carulli A, Babushok DV, Frey NV, Hexner EO, Martin ME, McCurdy SR, Stadtmauer EA, Loren AW, Paralkar VR, Maillard IP, Pratz KW: Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia Am J Hematol. : 2023.
Chippendale L, Freyer CW, Carulli A, Babushok DV, Frey NV, Gill SI, Hexner EO, Luger SM, Martin ME, Porter DL, Stadtmauer EA, Loren AW.: One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant J Oncol Pharm Pract : 2023.
Akahoshi Y, Spyrou N, Hogan WJ, Ayuk FA, DeFilipp Z, Weber D, Choe HK, Hexner EO, Rösler W, Etra AM, Sandhu KS, Yanik GA, Chanswangphuwana C, Kitko CL, Reshef R, Kraus S, Wölfl M, Eder M, Bertrand H, Qayed M, Merli P, Grupp SA, Aguayo-Hiraldo P, Schechter T, Ullrich E, Baez J, Beheshti R, Gleich S, Kowalyk S, Morales G, Young R, Kwon D, Nakamura R, Levine JE, Ferrara JLM, Chen YB: Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD Blood Adv. : 2023.
Ren JG, Xing B, Lv K, O'Keefe RA, Wu M, Wang R, Bauer KM, Ghazaryan A, Burslem GM, Zhang J, O'Connell RM, Pillai V, Hexner EO, Philips MR, Tong W: RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia J Clin Invest : 2023.
Al Malki MM, London K, Baez J, Akahoshi Y, Hogan WJ, Etra AM, Choe HK, Hexner EO, Langston A, Abhyankar SH, Ponce DM, DeFilipp Z, Kitko CL, Adekola KUA, Reshef R, Ayuk FA, Capellini A, Chanswangphuwana C, Eder M, Eng GW, Gandhi I, Grupp SA, Gleich S, Holler E, Javorniczky NR, Kasikis S, Kowalyk S, Morales G, Özbek U, Rösler W, Spyrou N, Young R, Yanik GA, Chen YB: Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease Blood Adv. : 2023.
Academic Contact Information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-151
3400 Civic Center Boulevard
Philadelphia,
PA
19104
Phone: 215-614-1847
Patient appointments: 800-789-7366